Miri Halperin Wernli, PhD

Executive President and Board Director

Dr. Halperin Wernli is a senior pharmaceutical and biomedical executive with over 30 years of strategic and operational leadership in the biopharmaceutical industry and a deep understanding of clinical psychiatry and of drug and product development in heavy regulated environments.

Dr. Halperin Wernli co-founded Creso Pharma, a cannabis company, and listed the company on the Australian Stock exchange (ASX) in October 2016. She is the Group CEO as well as an Executive Director on the Board. Creso develops cannabis and hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. Creso uses GMP development and manufacturing standards for its products as a reference of quality excellence with initial product registrations in Switzerland and has worldwide rights for a number of unique and proprietary innovative delivery technologies which enhance the bioavailability and absorption of cannabinoids. Creso’s products are currently commercialized in Switzerland, Europe, Oceania, South Africa and soon in Latin America.

Prior to founding Creso Pharma Dr. Halperin Wernli worked in clinical psychiatry in Swiss academic hospital settings and then held various global senior leadership positions in the pharma and biotech industries in Switzerland and in the US (Merck, Sharp and Dohme, Roche and Actelion pharmaceuticals) covering Product Development, R&D, and Strategic Marketing. Her extensive pharmaceutical industry and biomed research and development experience covers the full spectrum of areas and activities from Preclinical to Clinical Development and Strategy, to Drug Registration and Launch, across several Therapeutic Areas.

Dr. Halperin Wernli is a skilled clinician in child and adult psychiatry and an experienced Pharmaceutical leader with skills and broad expertise in Drug Development, Regulatory Affairs, Project & Portfolio Management, Development Finance & Controlling, and Corporate Strategy and Governance.

Robert Barrow Portrait

Robert Barrow

Chief Executive Officer
Daniel R Karlin, MD MA Portrait

Daniel R Karlin, MD MA

Chief Medical Officer
Miri Halperin Wernli, PhD Portrait

Miri Halperin Wernli, PhD

Executive President and Board Director
Bradford Cross Portrait

Bradford Cross

Chief Technology Officer
Donald Gehlert, PhD Portrait

Donald Gehlert, PhD

Chief Scientific Officer
Dave Guebert Portrait

Dave Guebert

Chief Financial Officer
Shahera St. John Portrait

Shahera St. John

VP, Programs
Peter Mack, PhD Portrait

Peter Mack, PhD

VP, Pharmaceutical Development
Nico Forte Portrait

Nico Forte

VP, Business Operations and Development
Carole Abel Portrait

Carole Abel

VP, EU Operations & Alliances, and Program Leader LSD
Jakub Klimes Portrait

Jakub Klimes

VP, Global Operations
Carol Gaines, MD Portrait

Carol Gaines, MD

Senior Medical Director
Stephen Schneider, PhD Portrait

Stephen Schneider, PhD

Sr. Director, Drug Substance Development
Lysa Triantafillou Portrait

Lysa Triantafillou

Senior Director of Clinical Quality Assurance
Jamie Freedman Portrait

Jamie Freedman

Director of Clinical Operations
Madeline Feldman Portrait

Madeline Feldman

Director of Strategy & Operations
Julie Tripp Portrait

Julie Tripp

Director of Toxicology
Jamileh Jemison, MD Portrait

Jamileh Jemison, MD

Digital Clinical Director
Todd Solomon, PhD Portrait

Todd Solomon, PhD

Digital Clinical Director
Martin Majernik Portrait

Martin Majernik

Director of Digital Product Lifecycle
Gennady Smagin Portrait

Gennady Smagin

Director of Pharmacology
Amber Doty Portrait

Amber Doty

Director of Pharmaceutical Development
Dustin Melton Portrait

Dustin Melton

Director of Pharmaceutical Development
Stanley D Glick, MD PhD Portrait

Stanley D Glick, MD PhD

Scientific Advisor
Natalie Wheeler, PhD Portrait

Natalie Wheeler, PhD

Medical Science Liaison with Dova Pharmaceuticals
Maurizio Fava, MD Portrait

Maurizio Fava, MD

Member, Scientific Advisory Board Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)
Peter Bergethon, MD Portrait

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.
Robert Malenka, MD PhD Portrait

Robert Malenka, MD PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University
Kenneth Alper, MD Portrait

Kenneth Alper, MD

Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine
Sarah McCallum, PhD Portrait

Sarah McCallum, PhD

Associate Professor of Neuroscience and Experimental Therapeutics (DNET) at Albany Medical College
John Rotrosen, MD Portrait

John Rotrosen, MD

Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry
Robert Dworkin, PhD Portrait

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester
Bryan L. Roth, MD, PhD Portrait

Bryan L. Roth, MD, PhD

Professor of Pharmacology, University of North Carolina School of Medicine; Director of the National Institute of Mental Health Psychoactive Drug Screening Program
Matthew W Johnson, PhD Portrait

Matthew W Johnson, PhD

Clinical Advisor
Peter Gasser, MD Portrait

Peter Gasser, MD

Clinical Advisor
Matthias Liechti, MD PhD Portrait

Matthias Liechti, MD PhD

Scientific Collaborator & Advisor
Kim PC Kuypers, PhD Portrait

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor
Sarah Y Vinson, MD Portrait

Sarah Y Vinson, MD

Board Director, Member of Audit Committee
Brigid Makes Portrait

Brigid Makes

Board Director, Chair of Audit Committee, Member of Compensation, Nomination and Governance Committee
Perry Dellelce Portrait

Perry Dellelce

Chairman, Member of Nomination and Governance Committees
Stephen L. Hurst, JD Portrait

Stephen L. Hurst, JD

Co-Founder and Board Director
Andreas Krebs Portrait

Andreas Krebs

Board Director
Carol Vallone Portrait

Carol Vallone

Board Director
JR Rahn Portrait

JR Rahn

Co-Founder
Scott Freeman, MD Portrait

Scott Freeman, MD

Co-Founder & Clinical Advisor
Leonard Latchman Portrait

Leonard Latchman

Co-Founder
Craig Conant Portrait

Craig Conant

Associate Director, Clinical Operations
Sarah Karas Portrait

Sarah Karas

Associate Director, Clinical Science
Rachel Chasse Portrait

Rachel Chasse

Sr Clinical Programs Manager
Matus Hajduk Portrait

Matus Hajduk

Sr Clinical Operations Manager
Alex Deschamps Portrait

Alex Deschamps

Clinical Research Coordinator
Shenique Gardner Portrait

Shenique Gardner

Clinical Research Coordinator
Cordia Simmons Portrait

Cordia Simmons

Clinical Trial Assistant
Jon Polaha Portrait

Jon Polaha

Financial Analyst
Klara Kleinova Portrait

Klara Kleinova

People & Business Ops Specialist
Georgios Lampadariou Portrait

Georgios Lampadariou

Senior Product Manager
Dana Rajtarova Portrait

Dana Rajtarova

Senior Business Development Manager
Ondrej Skala Portrait

Ondrej Skala

Associate Project Manager
Tomas Stefanicka Portrait

Tomas Stefanicka

Infrastructure Lead
Peter Dubec Portrait

Peter Dubec

Product Engineering Lead
Alexander Wald Portrait

Alexander Wald

iOS Engineer
Adam Kolar Portrait

Adam Kolar

Machine Learning Lead
Miguel Amável Pinheiro, PhD Portrait

Miguel Amável Pinheiro, PhD

Machine Learning Lead
Martin Pilch Portrait

Martin Pilch

Senior iOS Engineer
Branislav Rariga Portrait

Branislav Rariga

Senior Designer
Ezekiel Powdar Portrait

Ezekiel Powdar

Clinical Research Coordinator
Michal Lietava Portrait

Michal Lietava

Sr Finance Manager
Enriko Malinak Portrait

Enriko Malinak

Sr Legal Specialist
Alena Vankova Portrait

Alena Vankova

Talent & People Ops Specialist
Daniel Gavin Portrait

Daniel Gavin

Senior Recruiter
Maria Estrada Portrait

Maria Estrada

Executive Assistant to CEO
Wenna Wu Portrait

Wenna Wu

People & Business Ops Generalist
Michal Trebula Portrait

Michal Trebula

Finance Specialist
Libby McLean Portrait

Libby McLean

Junior Research & Operations Specialist